{"filing":{"accession_number":"0001635088-26-000088","cik":"0001635088","ticker":"ROIV","company_name":"Roivant Sciences Ltd.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"roiv-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1635088/000163508826000088/roiv-20260806.htm"},"events":[{"id":25919,"run_id":23534,"accession_number":"0001635088-26-000088","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Roivant issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing consolidated financial statements including revenue, operating expenses, net loss of $290.6 million, and cash position of $3.9 billion. The filing explicitly states this is Item 2.02 Results of Operations and Financial Condition with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","company_name":"Roivant Sciences Ltd.","ticker":"ROIV","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26858,"accession_number":"0001635088-26-000088","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Roivant issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing consolidated financial statements including revenue, operating expenses, net loss of $290.6 million, and cash position of $3.9 billion. The filing explicitly states this is Item 2.02 Results of Operations and Financial Condition with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:45.052845+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26858,"accession_number":"0001635088-26-000088","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Roivant issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing consolidated financial statements including revenue, operating expenses, net loss of $290.6 million, and cash position of $3.9 billion. The filing explicitly states this is Item 2.02 Results of Operations and Financial Condition with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:45.052845+00:00","company_name":"Roivant Sciences Ltd.","ticker":"ROIV","filing_date":"2026-08-06"}]}